FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3015280884> ?p ?o ?g. }

• W3015280884 endingPage "984" @default.
• W3015280884 startingPage "979" @default.
• W3015280884 abstract "Objective: To report the outcomes of percutaneous nephrolithotomy (PCNL) in horseshoe kidneys (HSK) in 12 institutions worldwide and evaluate the impact of patient position during operation. Methods: We carried out a retrospective analysis of PCNL procedures performed between 2008 and 2018 in patients with HSK. Pre-, peri-, and postoperative data were collected, and a subgroup analysis was performed according to patient position. Success was defined as an absence of >4-mm fragments. Values of p < 0.05 were considered significant. Results: We analyzed 106 procedures. The transfusion, complication, and immediate success rates (ISRs) were 3.8%, 17.5%, and 54.7%, respectively. The final success rate (FSR) increased to 72.4% after a mean of 0.24 secondary procedures. Logistic regression showed that higher body mass index (BMI) and stone size were significantly associated with residual fragments ≥4 mm. Sixty-seven patients (63.2%) were treated in prone and 39 (36.8%) in supine position. The prone group had a significantly higher BMI than the supine group (30.1 vs 27.7, p = 0.024). The transfusion, complication, and ISRs between the prone and supine groups were 4.5% vs 2.6% (p = 0.99), 16.9% vs 18.4% (p = 0.99), and 52.5% vs 69.2% (p = 0.151), respectively. Surgical time was significantly longer in the prone group (126.5 vs 100 minutes, p = 0.04). Upper pole was the preferred access in 80.3% of the prone group and 43.6% of the supine group (p < 0.001). The prone group had significantly more Clavien 2 complications than the supine (p = 0.013). The FSR in the prone and supine groups increased to 66.1% and 82.1% after 0.26 and 0.21 secondary procedures, respectively. No complications higher than Clavien 3 occurred. Conclusion: PCNL in patients with HSK is safe and effective with a low complication rate. Higher BMI and stone size negatively impacted outcomes. Supine PCNL may be an option for treating kidney stones in patients with HSK." @default.
• W3015280884 created "2020-04-17" @default.
• W3015280884 creator A5001895437 @default.
• W3015280884 creator A5005863160 @default.
• W3015280884 creator A5011999780 @default.
• W3015280884 creator A5014280361 @default.
• W3015280884 creator A5015212715 @default.
• W3015280884 creator A5015539324 @default.
• W3015280884 creator A5020056284 @default.
• W3015280884 creator A5027043847 @default.
• W3015280884 creator A5028900282 @default.
• W3015280884 creator A5033497490 @default.
• W3015280884 creator A5035460779 @default.
• W3015280884 creator A5041489697 @default.
• W3015280884 creator A5049938213 @default.
• W3015280884 creator A5057433346 @default.
• W3015280884 creator A5063835560 @default.
• W3015280884 creator A5070020713 @default.
• W3015280884 creator A5076379486 @default.
• W3015280884 creator A5077312358 @default.
• W3015280884 creator A5084505813 @default.
• W3015280884 creator A5087224635 @default.
• W3015280884 date "2021-07-01" @default.
• W3015280884 modified "2023-10-16" @default.
• W3015280884 title "Percutaneous Nephrolithotomy in Horseshoe Kidneys: Results of a Multicentric Study" @default.
• W3015280884 cites W1053401185 @default.
• W3015280884 cites W1838613272 @default.
• W3015280884 cites W1963620774 @default.
• W3015280884 cites W1967562789 @default.
• W3015280884 cites W2048812686 @default.
• W3015280884 cites W2096715689 @default.
• W3015280884 cites W2160241148 @default.
• W3015280884 cites W2162024884 @default.
• W3015280884 cites W2323522925 @default.
• W3015280884 cites W2403072155 @default.
• W3015280884 cites W2583975554 @default.
• W3015280884 cites W2585208308 @default.
• W3015280884 cites W2783358736 @default.
• W3015280884 cites W2783516133 @default.
• W3015280884 cites W2803858162 @default.
• W3015280884 cites W2898219712 @default.
• W3015280884 cites W2941729527 @default.
• W3015280884 cites W2965651752 @default.
• W3015280884 doi "https://doi.org/10.1089/end.2020.0128" @default.
• W3015280884 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32292038" @default.
• W3015280884 hasPublicationYear "2021" @default.
• W3015280884 type Work @default.
• W3015280884 sameAs 3015280884 @default.
• W3015280884 citedByCount "12" @default.
• W3015280884 countsByYear W30152808842020 @default.
• W3015280884 countsByYear W30152808842021 @default.
• W3015280884 countsByYear W30152808842022 @default.
• W3015280884 countsByYear W30152808842023 @default.
• W3015280884 crossrefType "journal-article" @default.
• W3015280884 hasAuthorship W3015280884A5001895437 @default.
• W3015280884 hasAuthorship W3015280884A5005863160 @default.
• W3015280884 hasAuthorship W3015280884A5011999780 @default.
• W3015280884 hasAuthorship W3015280884A5014280361 @default.
• W3015280884 hasAuthorship W3015280884A5015212715 @default.
• W3015280884 hasAuthorship W3015280884A5015539324 @default.
• W3015280884 hasAuthorship W3015280884A5020056284 @default.
• W3015280884 hasAuthorship W3015280884A5027043847 @default.
• W3015280884 hasAuthorship W3015280884A5028900282 @default.
• W3015280884 hasAuthorship W3015280884A5033497490 @default.
• W3015280884 hasAuthorship W3015280884A5035460779 @default.
• W3015280884 hasAuthorship W3015280884A5041489697 @default.
• W3015280884 hasAuthorship W3015280884A5049938213 @default.
• W3015280884 hasAuthorship W3015280884A5057433346 @default.
• W3015280884 hasAuthorship W3015280884A5063835560 @default.
• W3015280884 hasAuthorship W3015280884A5070020713 @default.
• W3015280884 hasAuthorship W3015280884A5076379486 @default.
• W3015280884 hasAuthorship W3015280884A5077312358 @default.
• W3015280884 hasAuthorship W3015280884A5084505813 @default.
• W3015280884 hasAuthorship W3015280884A5087224635 @default.
• W3015280884 hasConcept C125567185 @default.
• W3015280884 hasConcept C126322002 @default.
• W3015280884 hasConcept C126894567 @default.
• W3015280884 hasConcept C141071460 @default.
• W3015280884 hasConcept C151956035 @default.
• W3015280884 hasConcept C163100246 @default.
• W3015280884 hasConcept C167135981 @default.
• W3015280884 hasConcept C2780221984 @default.
• W3015280884 hasConcept C2780813298 @default.
• W3015280884 hasConcept C2780885103 @default.
• W3015280884 hasConcept C71924100 @default.
• W3015280884 hasConcept C81182388 @default.
• W3015280884 hasConceptScore W3015280884C125567185 @default.
• W3015280884 hasConceptScore W3015280884C126322002 @default.
• W3015280884 hasConceptScore W3015280884C126894567 @default.
• W3015280884 hasConceptScore W3015280884C141071460 @default.
• W3015280884 hasConceptScore W3015280884C151956035 @default.
• W3015280884 hasConceptScore W3015280884C163100246 @default.
• W3015280884 hasConceptScore W3015280884C167135981 @default.
• W3015280884 hasConceptScore W3015280884C2780221984 @default.
• W3015280884 hasConceptScore W3015280884C2780813298 @default.
• W3015280884 hasConceptScore W3015280884C2780885103 @default.
• W3015280884 hasConceptScore W3015280884C71924100 @default.
• W3015280884 hasConceptScore W3015280884C81182388 @default.

• next